A controlled trial of automated delivery of three intravenous anesthetics using automated delivery system for total intravenous anesthesia

Not Applicable

• Conditions: Patients who are scheduled for surgery under total intravenous anesthesia with propofol, remifentani; General anesthesia; D000768

• Registration Number: JPRN-jRCT2052190124
• Lead Sponsor: Shigemi Kenji

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-03-26
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

1. Male and female patients over 20 years old at the time of informed consent
2. Patients with ASA physical status of 1, 2, and 3 who are scheduled for surgery under general anesthesia
3. Patients who understand the contents of this study and are willing to provide written informed consent for participation in this study

Exclusion Criteria

1. Patients with a history of hypersensitive to propofol, remifentanil, rocuronium or sugammadex.
2. Patients who cannot connected BIS Sensor for placement on the forehead.
3. Patients who cannot received rocuronium after first single dose.
4. Patients who cannot measured non-invasive sphygmomanometer.
5. Patients undergoing surgery with hypothermia.
6. Patients undergoing cardiovascular surgery.
7. Patients undergoing surgery with nerve block.
8. Patients who are pregnant or lactating.
9. Patients who participated in another trial within 12 weeks before obtaining informed consent.
10. Patients who are determined not to be eligible for participation in this study by the research director.

Study & Design

• Study Type: Interventional
• Study Design: Not specified